WO1997028812A3 - Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) - Google Patents

Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) Download PDF

Info

Publication number
WO1997028812A3
WO1997028812A3 PCT/EP1997/000558 EP9700558W WO9728812A3 WO 1997028812 A3 WO1997028812 A3 WO 1997028812A3 EP 9700558 W EP9700558 W EP 9700558W WO 9728812 A3 WO9728812 A3 WO 9728812A3
Authority
WO
WIPO (PCT)
Prior art keywords
enterococcus faecium
vre
vancomycin
antibiotics
infections
Prior art date
Application number
PCT/EP1997/000558
Other languages
French (fr)
Other versions
WO1997028812A2 (en
Inventor
Herman Goossens
Giuliano Frigerio
Original Assignee
Giuliani S A
Herman Goossens
Giuliano Frigerio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani S A, Herman Goossens, Giuliano Frigerio filed Critical Giuliani S A
Publication of WO1997028812A2 publication Critical patent/WO1997028812A2/en
Publication of WO1997028812A3 publication Critical patent/WO1997028812A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to the use of an Enterococcus faecium strain for preparing a medicinal product suitable for the therapeutical treatment of infections, with particular reference to enterocolites, supported by Enterococcus faecium strains resistant to antibiotics and in particular, vancomycin, the so-said 'VRE' strains. In particular, Enterococcus faecium is taken into consideration and disclosed which belongs to that strain referred to as 'SF68'. The invention also discloses and relates to pharmaceutical compositions for such a use.
PCT/EP1997/000558 1996-02-08 1997-02-05 Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre) WO1997028812A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI96A000239 1996-02-08
IT96MI000239A IT1282586B1 (en) 1996-02-08 1996-02-08 PHARMACEUTICAL COMPOSITIONS FOR THE BIOLOGICAL TREATMENT OF INFECTIONS DUE TO STRAINS OF ENTEROCOCCUS FAECIUM RESISTANT TO

Publications (2)

Publication Number Publication Date
WO1997028812A2 WO1997028812A2 (en) 1997-08-14
WO1997028812A3 true WO1997028812A3 (en) 1997-10-02

Family

ID=11373201

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/000558 WO1997028812A2 (en) 1996-02-08 1997-02-05 Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre)

Country Status (2)

Country Link
IT (1) IT1282586B1 (en)
WO (1) WO1997028812A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513759A (en) 1996-02-26 2001-09-04 カリフォルニア・インスティチュート・オブ・テクノロジー Improved polyamide binding in the minor groove of double-stranded DNA
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
CN1249081C (en) 1998-12-23 2006-04-05 施万制药 Glycopeptide derivatives and pharmaceutical compositions containing same
CN1550545A (en) * 2003-05-15 2004-12-01 Method of producing lactic bacteria and killed lactic bacterial cells belonging to the enterococcus
AU2003304444A1 (en) * 2003-08-26 2005-03-10 Zakrytoe Aktsionernoe Obschestvo "Alef" Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
KR20070092719A (en) 2004-11-29 2007-09-13 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 Glycopeptide antibiotic monomer derivatives
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
US20070280964A1 (en) * 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
ITMI20060860A1 (en) * 2006-05-02 2007-11-03 Truffini & Regge Farmaceutici Srl COMPOSITIONS FOR TEETH AND GUMS HEALTH CONTAINING REVIVABLE ENABLED EUBIOTIC MICROORGANISMS
WO2009081958A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivative
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
WO2023247472A1 (en) * 2022-06-22 2023-12-28 Cerbios-Pharma Sa Probiotic for use in the treatment of inflammatory alterations of the intestinal mucosa, particularly obesity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1112479B (en) * 1979-04-02 1986-01-13 Giuliani Sa PHARMACEUTICAL COMPOSITION PARTICULARLY SUITABLE FOR THE THERAPY OF ENTERITES AND GENERIC DIARROIC DISEASES
EP0405569A1 (en) * 1989-06-30 1991-01-02 Cernitin S.A. Product with antimicrobial activity, its process of isolation from the culture brew containing streptococcus faecium and the pharmaceutical preparation containing this product with antimicrobial activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1112479B (en) * 1979-04-02 1986-01-13 Giuliani Sa PHARMACEUTICAL COMPOSITION PARTICULARLY SUITABLE FOR THE THERAPY OF ENTERITES AND GENERIC DIARROIC DISEASES
EP0405569A1 (en) * 1989-06-30 1991-01-02 Cernitin S.A. Product with antimicrobial activity, its process of isolation from the culture brew containing streptococcus faecium and the pharmaceutical preparation containing this product with antimicrobial activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 8721, Derwent World Patents Index; Class B05, AN 87-145571, XP002035793 *
EDOUARD LOISEAU: "PLACE DE L'ENTÉROCOQUE SF 68 DANS LA PRÉVENTION ET LE TRAITEMENT DES GASTRO-ENTÉRITES INFECTIEUSES ET LIÉES AUX ANTIBIOTIQUES", REVUE MEDICALE DE LA SUISSE ROMANDE, vol. 114, no. 7, July 1994 (1994-07-01), pages 651 - 654, XP000674785 *
LISA L. DENVER ET AL.: "PERSISTENCE OF VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM GASTROINTESTINAL TRACT COLONIZATION IN ANTIBIOTIC-TREATED MICE", MICROBIAL DRUG RESISTANCE, vol. 2, no. 4, 1996, pages 415 - 421, XP000674789 *
MITRA A K ET AL: "A DOUBLE-BLIND, CONTROLLED TRIAL OF BIOFLORIN (STREPTOCOCCUS FAECIUM SF68) IN ADULTS WITH ACUTE DIARRHEA DUE TO VIBRIO CHOLERAE AND ENTEROTOXIGENIC ESCHERICHIA COLI", GASTROENTEROLOGY, vol. 99, no. 4, October 1990 (1990-10-01), pages 1149 - 1152, XP000670317 *

Also Published As

Publication number Publication date
IT1282586B1 (en) 1998-03-31
ITMI960239A1 (en) 1997-08-08
WO1997028812A2 (en) 1997-08-14
ITMI960239A0 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
WO1997028812A3 (en) Pharmaceutical compositions for biological treatment of infections by enterococcus faecium strains resistant to antibiotics and to vancomycin in particular (vre)
BG101118A (en) Therapeutical compounds
UA56989C2 (en) PHYSIOLOGICALLY ACTIVE PEG-CONJUGATE OF a-INTERFERON, A METHOD FOR PREPARING THE SAME, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR TREATMENT OR PROPHYLAXIS OF IMMUNOMODULAR DISEASES
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
CA2191213A1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
CA2213302A1 (en) Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
AU2843689A (en) 2-(2-hydroxy-3-phenoxypropylamino) ethylphenoxymethyl compounds
CA2136331A1 (en) New pharmaceutical uses of krill enzymes
AU3855297A (en) Pharmaceutical composition for treating papillomavirus tumours and infection
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
CA2255539A1 (en) Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
AU2967595A (en) Anti-protozoan methods and materials
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
WO1996022305A3 (en) Modified peptides
AU7761598A (en) 20(s) camptothecin glycoconjugates
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
GR1002576B (en) Pharmaceutical compositions and a process for the preparation thereof.
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
GR3035710T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them
AU7076494A (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
EP0386920A3 (en) 2-hydroxy-3-thienyloxypropylamino derivatives
WO1989000571A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
AU7858794A (en) Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97528161

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase